rate contract for group no.3, respiratory medicine. tender for the supplies of drugs and pharmaceuticals, labchemicals, x ray films and chemicals, surgicalsutures and dressings, vaccines, sera etc. and general items for the year 2023 25. , cap/tab: acebrophylline 200 mg sr , syrup: ambroxol hydrochloride ip 30mg + terbutaline sulphate ip equivalent to terbutaline 2.50mg + guaiphenesin ip 50mg + menthol ip 0.5mg , syrup: ambroxyl hcl ip 30 mg + levosalbutamol sulphate equivalent to levosalbutamol 1 mg + guaiphensin 50 mg/5ml. , nasal spray: azelastine 140 mcg + fluticasone propionate 50 mcg per dose , nasal spray: azelastine 140 mcg per spray , nebulizing solution : budesonide 0.5 mg , nebulizing solution : budesonide 1 mg , mdi: budesonide 100 mcg/ 1puff , dpi: budesonide rotacap (200 mcg/rotacap) , tab: deflazacort 30 mg , tab: deflazacort 6 mg , device: device for rotacaps - dual chamber dpi device , syrup: dextromethorphan 10 mg, guaifenesin 100 mg, phenylephrine 5 mg , chlorpheniramine maleate 4 mgper 5 ml (sugar free) , syrup: doxophylline 100 mg /5 ml , tab: doxophylline 400 mg , tab: doxophylline 400 mg + ambroxyl 30 mg , dpi: dpi- indacaterol 75 mcg and budesonide powder200mcg respicaps , dpi: dpi- indacaterol 75 mcg and budesonide powder400mcg respicaps , syp/susp.: each 5 ml contains codeine phosphate 10 mg + triprolidinehcl 1.25mg , syp/susp.: each 5 ml suspension contains: levocloperastine fendizoate 35.4 mg equivalent to levocloperastine hydrochloride 20 mg in a flavoured sugar free base , syp/susp.: each 5ml contains levodropropizine i.p 30mg chlorpheniramine maleate i.p. 2mg , syp/susp.: each 5ml contains: dextromethorphan hydrobromide ip10mg + chlorpheniramine maleate i p 4mg + menthol ip 1mg , cap: each capsule contains: fluticasone furoate 200 mcg + vilanterol trifenatate equ. vilanterol 25mcg , dpi: each capsule contains: fluticasone propionate ip 250 mcg formoterol fumarate dihydrate ip 12 mcg glycopyrronium bromide equivalent to glycopyrronium 12.5 mcg excipients q.s. approved colors used in empty capsules , dpi: each capsule contains: formoterol 12mcg+glycopyrronium 25mcg + budesonide 400 mcg , cap: each capsule contains: nintedanib soft gelatin capsules 150 mg , mdi: each metered inhalation contains: glycopyrrolate ip 9.0 mcg and formoterol fumarate 4.8 mcg and budesonide ip 160 mcg , nasal spray: fluticasone fuorate 27.5mcg + oxymetazoline hcl 50mcg , nasal spray: fluticasone furoate 27.5 mcg per dose , nasal spray: fluticasone propionate 50 mcg/1 dose , mdi: formetrol 6 mcg + budesonide 400 mcg /1 puff , dpi: formoterol 12 mcg + budesonide 400 mcg rotacap , dpi: formoterol 12 mcg + fluticasone 500 mcg rotacap , dpi: formoterol 12 mcg + tiotropium 18 mcgrotacap , dpi: formoterol 12 mcg+ glycopyrronium 25 mcg rotacap dpi , mdi: formoterol 6 mcg + budesonide 100 mcg/ 1puff , dpi: formoterol 6 mcg + budesonide 200 mcgrotacap , mdi: formoterol 6 mcg + budesonide 200 mcg/ 1puff , dpi: formoterol 6 mcg + budesonide 400 mcg rotacap , mdi: formoterol 6 mcg + fluticasone 250 mcg per dose , dpi: formoterol 6 mcg + fluticasone 250 mcg rotacap , mdi: formoterol 6mcg+ budesonide 100mcg / 1 puff , dpi: formoterol 6mcg+ glycopyrronium 25 mcg rotacap , respule: formoterol fumarate 20mcg + budesonide 0.5mg , respule: formoterol fumarate 20mcg + budesonide 1 mg , dpi: indacaterol 110 mcg with glycopyrronium 50mcg per rotacap , dpi: indacaterol 150 mcg cap rotacap , solution: ipratropium bromide bp 250 mcg/ml , respule: levosalbutamol 0.63mg + ipratropium bromide 500 mcg , nebulizing solution : levosalbutamol 1.25 mg + ipratropium bromide 500mcg. , respule: levosalbutamol 1.25mg + budesonide 0.5mg respules , mdi: levosalbutamol 50 mcg /1 puff , mdi: mdi- indacaterol 75 mcg and budesonide 200mcg inhaler with dose counter , mdi: mdi- vilanterol 12.5 mcg and fluticasone furoate 100mcg inhalation with dose counter , mdi: mdi- vilanterol 12.5 mcg and fluticasone furoate 50mcg inhalation with dose counter , nasal spray: mometasone 50 mcg /dose , tab: montelukast10 mg , tab: montelukast10 mg + fexofenadine 120 mg , tab: montelukast10 mg + levocetirizine 5 mg , tab: montelukast4 mg , tab: montelukast5 mg , syrup: montelukast 4 mg + levocetrizine 2.5 mg per 5 ml , cap/tab: n. acetylcysteine 600 mg , device: non static dry powder capsule delivery device , spacer device: non static spacer with unidirectional valve 150 mlcapacity , tab: perfenidone 200 mg , respule: salbutamol2.5 mg , mdi: salbutamol 100 mcg/ 1puff , syrup: salbutamol 1mg + ambroxol hydrochloride ip 15 mg per 5 ml , dpi: salbutamol rotacap (200 mcg) , dpi: salmeterol 50 mcg + fluticasone 250 mcg rotacap , mdi: salmeterol 50 mcg + fluticasone 500 mcg per dose mdi , dpi: salmeterol 50 mcg + fluticasone 500 mcg rotacap , mdi: salmetrol 25 mcg+ fluticasone 250 mcg/ 1 puff , mdi: salmetrol 25 mcg + fluticasone 125 mcg / 1 puff , rotacap: salmetrol 50 mcg+fluticasone 100mcg , solution: sodium chloride inhalation solution usp 3% w/v , syrup: syrup bromhexine hydrochloride ip 4mg/5ml each 5 ml contains: bromhexine hydrochloride ip 4 mgflavoured syrupy base q.s , tab: tab. bilastine20mg + montelukast 10mg – film coated bi-layered , tab: tab.levocetrizine 5mg + montelukast10mg + ambroxol 75 mg(sr) , syrup: terbutaline 1.25mg +bromhexinehcl 8 mg + guaifenesin50 mg + menthol 0.5mg / 5 ml(sugar free) , syrup: terbutaline sulphate 1.25 mg + bromehexine hcl 2 mg + guafenesin 50 mg+ menthol 0.5 mg/5 ml , syrup: theophylline 100 mg/5ml , dpi: tiatropium rotacap (18 mcg) , mdi: tiotropium 9 mcg / 1puff , tab: tranexamic acid 250 mg